Leila Alland - Sep 9, 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Medical Officer
Signature
/s/ Winston Kung, by power of attorney
Stock symbol
PMVP
Transactions as of
Sep 9, 2022
Transactions value $
$0
Form type
4
Date filed
9/13/2022, 04:23 PM
Previous filing
Feb 28, 2022
Next filing
Sep 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Award $0 +52.2K $0.00 52.2K Sep 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024.